Abbreviated glucose testing identifies highest risk pregnant women during COVID-19

Random plasma glucose tests at 12 weeks’ gestation and fasting plasma glucose or HbA1c at 28 weeks’ gestation can safely identify women with hyperglycemia at risk for suboptimal pregnancy outcomes during COVID-19, study data show. In a retrospective analysis published in Diabetic Medicine, researchers found that the laboratory tests “perform adequately” for risk

Read the full article here

Related Articles